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ABSTRACT
Objectives: Construction of a simple preoperative risk
score for patients in high risk of potentially preventable
‘medical’ complications. Secondary objectives were to
construct simple preoperative risk scores for ‘severe
medical’, ‘surgical’ and ‘total’ potentially preventable
complications.
Design: Prospective observational study.
Setting: Elective primary unilateral total hip and knee
arthroplasty with prospectively collected preoperative
patient characteristics; similar standardised fast-track
protocols; evaluation of complications through
discharge and medical records; and complete 90 days
follow-up through nationwide databases.
Participants: 8373 consecutive unselected total hip
arthroplasty (THA) and knee arthroplasty from January
2010 to November 2012.
Results: There were 557 procedures (6.4%) followed
by potentially preventable complications resulting in
hospitalisation >4 days or readmission. Of 22
preoperative characteristics, 7 were associated with
379 (4.2%) potentially preventable ‘medical’
complications. Patients with ≥2 of the following, age
≥80 years, anticoagulant therapy, pulmonary disease,
pharmacologically treated psychiatric disorder, anaemia
and walking aids, composed 19.1% of the procedures;
55.7% constituted potentially preventable ‘medical’
complications that were mainly falls, mobilisation
issues, pneumonias and cardiac arrhythmias. The
number needed to be treated for a hypothetical
intervention leading to 25% reduction in potentially
preventable ‘medical’ complications was 34. THA, use
of walking aids and cardiac disease were
associated with 189 (2.2%) ‘surgical’ complications,
but no clinically relevant preoperative prediction was
possible.
Conclusions: Preoperative identification of patients at
high risk of preventable ‘medical’, but not ‘surgical’,
complications is statistically possible. However, clinical
relevance is limited. Future risk indices should differ
between ‘medical’ and ‘surgical’ complications, and
also consider ‘preventability’ of these.
Trial registration number: NCT01515670.
INTRODUCTION
As with any multifactorial problem, predic-
tion of postoperative morbidity in surgical
patients is difﬁcult. However, the potential
beneﬁt of being able to identify and ultim-
ately allocate high-risk patients to an appro-
priate level of care is vast. For example, more
than 80% of postoperative deaths have been
found to occur in a subgroup of high-risk
patients with a likely higher number of non-
fatal complications.1
Several risk stratiﬁcation tools have been
developed to help clinicians decide whether
preoperative optimisation of organ function,
changes in perioperative care or postpone-
ment of surgery may be indicated. Starting
with the American Society of
Anesthesiologists’ Physical Status score
(ASA),2 the other scores, such as the
Physiological and Operative Severity Score
for enUmeration of Mortality and Morbidity
(POSSUM),3 the Surgical APGAR score4 and
the Charlson Comorbidity Index,5 have also
been found useful for predicting post-
operative morbidity, and may be supplemen-
ted by cardiopulmonary exercise tests.6 7
Strengths and limitations of this study
▪ A large cohort of patients with total hip arthro-
plasty and total knee arthroplasty with standar-
dised fast-track protocols and prospective
recording on preoperative morbidity.
▪ Detailed follow-up on postoperative complica-
tions through discharge records.
▪ Differentiation between ‘medical’ and ‘surgical’
complications.
▪ Evaluation of preventability of complications is
subjective.
▪ Validation in other types of fast-track surgery is
needed.
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Recently, internet-based risk calculators published by
the American College of Surgeons’ National Surgical
Quality Improvement Program, have been developed for
a variety of procedures and outcomes.8 9 However, the
extent to which these are used in clinical practice is
uncertain, and the ideal preoperative risk stratiﬁcation
tool has yet to be found.10 Furthermore, if used to guide
postoperative care, such a tool should be developed in
patients receiving up-to-date evidence-based care and
must consider the pathophysiological mechanisms
leading to the outcome of interest, thus enabling
rational inteventions.11
In this context, it must be considered that many risk
indices were developed at a time when perioperative
care was different from today. Thus, the introduction of
enhanced recovery programmes or the so-called ‘fast-
track’ surgery12 has led to changes in surgical, anaes-
thetic and rehabilitative practices, which have improved
postoperative recovery, reduced morbidity and conse-
quently reduced length of hospital stay (LOS) without
increasing readmissions.13 However, whether traditional
perioperative risk assessment is transferable to the
concept of fast-track surgery remains to be answered.11
In this context, recent studies in fast-track total hip
arthroplasty (THA) and total knee arthroplasty (TKA)
have found that traditional risk factors, such as age,14 15
obesity,16 cardiopulmonary disease,15 smoking or alcohol
use,16 17 and type 2 diabetes,18 may have less inﬂuence
on LOS and postoperative morbidity than has been esti-
mated in previous studies with conventional care. In
addition, the types of postoperative morbidity in fast-
track surgery may also differ from previous reports on
conventional care. Thus, low incidences of delirium,19
venous thromboembolic events20 as well as myocardial
infarctions and overall mortality have been found in fast-
track THA and TKA.21 The combination of different risk
proﬁles and incidences of postoperative complications
in fast-track surgery may inﬂuence the accuracy of previ-
ously established risk indices, thereby calling for
procedure-speciﬁc studies with implemented fast-track
methodology.22 Finally, assessment of ‘medical’ versus
‘surgical’ complications rather than traditional assess-
ment of ‘all cause’ morbidity is necessary to deﬁne inter-
ventional strategies.11
The present study attempted to develop a simple
numerical score to identify patients at high risk of spe-
ciﬁc potentially preventable postoperative ‘medical’ and
‘surgical’ complications, which is based on previous
works on patient-related risk factors and postoperative
morbidity in fast-track THA and TKA.15 17 23–25
METHODS
The study population was based on a previously pub-
lished cohort from the Lundbeck Foundation Centre for
Fast-Track Hip and Knee Replacement database (LCDB)
from January 2010 to November 2012, thus ensuring a
high degree of details regarding postoperative morbidity
resulting in LOS >4 and 90 days readmissions.15 18 25
The cut-off of >4 days was chosen based on median LOS
being 3 days in 2010.15 Eight large Danish Regional/
University hospitals with dedicated arthroplasty depart-
ments performing >400 procedures/year are currently
reporting to the LCDB, which is a prospective registry
on preoperative comorbidity registered on ClinicalTrials.
gov (ID: NCT01515670). None of the previous investiga-
tions based on this cohort have attempted to summarise
relevant risk factors into a risk score regarding poten-
tially preventable complications.
All departments have similar fast-track protocols,
including spinal anaesthesia, opioid-sparing multimodal
analgesia, early mobilisation and with planned discharge
to own home.26 The data in the LCDB are cross-
referenced with the Danish National Patient Registry for
information on the index surgery and 90 days follow-up
on readmissions and mortality. The Danish National
Patient Registry collects data on all admissions in Danish
with a data completeness of >99%.27 Information on pre-
operative use of continuous anticoagulants, pharmaco-
logical antidiabetic and psychiatric treatment is acquired
from the Danish National Database on Reimbursed
Prescriptions which registers any prescription receiving
reimbursement dispensed outside hospitals (the usual
practice in the government-funded Danish healthcare
system).28
LOS was counted as the number of postoperative
nights in hospital, including transferrals to other depart-
ments. Any case of LOS >4 days or readmissions within
90 days were investigated using discharge records to
identify the primary cause. This was done by the
primary author (CCJ) who consulted the senior author
(HK) in case of doubts. If information in the discharge
record was deemed insufﬁcient, a review of the entire
medical record was performed by CCJ and HK that was
followed by discussion until agreement with relation to
surgery. In case of death, the complete medical records/
autopsy reports and death certiﬁcates were obtained.
Only surgery-related readmissions resulting in overnight
stay in hospital were considered relevant, that is, uncom-
plicated urinary tract infections, syncope and acute wor-
sening of chronic obstructive pulmonary disease
(COPD) without antibiotic treatment after postoperative
day 30 and other admissions obviously unrelated to
index surgery (evaluation of newly discovered cancer,
eye surgery, cholecystitis, allergic reactions unrelated to
postoperative treatment, etc.) were excluded. Causes of
LOS >4 days and readmissions were subsequently divided
into ‘surgical’ (related directly to the surgical technique
and prosthesis components) and ‘medical’ (related to
the surgical procedure or pre-existing conditions but
potentially reversible by non-surgical intervention) based
on previous work.15
Following initial screening for relation to surgery, an
evaluation on the potential preventability of the reasons
for LOS>4 days and readmissions was conducted by both
CCJ and HK. This evaluation focused on whether an
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intervention either preoperatively or during the ﬁrst 2–3
postoperative days could potentially have prevented LOS
>4 days or readmission. Most ‘medical’ conditions were
included a priori if occurring during primary admission
or resulting in readmission ≤30 days after surgery, while
some conditions required further evaluation of medical
records followed by discussion until mutual agreement
was reached by both reviewers. A few conditions, that is,
urinary retention (n:12) and uncomplicated urinary
tract infection (n:18), were excluded due to lack of
preoperative information on voiding difﬁculties, post-
operative intermittent catheterisations, and chronic
urinary tract infection. Furthermore, postoperative ileus
was excluded due to its rarity (n:7), and multifactorial
pathogenesis (table 1) ‘surgical’ readmissions were
included ≤90 days after surgery as these often present
later than ‘medical’ complications (table 1). Finally, of
the included complications, we classiﬁed the following
as severe: conﬁrmed cardiac complications, severe hypo-
tension unresponsive to ﬂuids, cerebral stroke or
Table 1 Included and excluded types of complications
‘Medical’ ‘Surgical’
Included a priori as potentially preventable if resulting in LOS ≥4 or
30 days readmission*:
Myocardial infarction
Unstable angina
Heart failure
Cardiac arrhythmia (LOS >4 days or after discharge but ≥7 days after
surgery)
Cerebral stroke/transient cerebral ischaemia
Delirium/psychosis
Venous thromboembolic events
Pneumonia/acute worsening of chronic obstructive disease
Sepsis without wound infection
Unexplained infection
Falls
Renal infection with increase in creatinine and fluid/diuretic treatment
only
Fluid/electrolyte derangement treated with
fluids only
Renal infection resulting in dialysis
Mobilisation issues preventing fulfilling functional discharge criteria
within 4 days or need of inhospital rehabilitation after discharge
Opioid-related side effects
Included a priori as potentially preventable if resulting
in LOS >4 or 30 days readmission:
Hip dislocation not caused by falling
Knee manipulation under anaesthesia
Wound infections with antibiotic treatment
Superficial infection with wound incision
Deep infection with removal of prosthetic components
Included for further evaluation on preventability:
Unexplained hypotension/hypertension
Unexplained fainting or dizziness
Unexplained dyspnoea
Constipation unrelated to opioids
Complications related to existing comorbidity†
Any condition not fitting other descriptions
Included for further evaluation on preventability:
Excluded a priori as being potentially preventable by perioperative
intervention:
No recorded morbidity (LOS >4 days only)
Postoperative ileus
Diarrhoea
Disproved venous thromboembolic event
Disproved myocardial infarction
Disproved wound infection
Social considerations
Excluded a priori as being potentially preventable by
perioperative intervention:
Postanaesthetic complications
Periprosthetic fracture without recorded trauma
Revision due to prosthetic malfunction
Other planned reoperations
Systemic arterial thrombosis/pseudoaneurism
Excluded a priori due to lack of information necessary for qualified
evaluation:
Gastric ulcer/gastritis
Urinary retention
Uncomplicated urinary tract infection
Pain
Excluded a priori due to lack of information necessary
for qualified evaluation:
Major postoperative haematoma/swelling
Major intraoperative bleeding
Minor wound bleeding
*Anaemia requiring blood transfusion despite no recorded major intraoperative bleed.
†For example, difficulties with vitamin K or antihyperglycaemic treatment, management of sleep apnoea.
LOS, length of stay.
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transient cerebral ischaemia, delirium or psychosis, con-
ﬁrmed venous thromboembolic events, pneumonia, wor-
sening of COPD, unexplained dyspnoea with severe
hypoxaemia, sepsis, falls, renal affection requiring dialy-
sis, prosthetic infections with surgical interventions, hip
dislocations and knee manipulation under anaesthesia
(MUA). Only the ﬁrst potentially preventable ‘medical’
or ‘surgical’ complication was included for analysis;
however, a subsequent severe complication was included
if the ﬁrst complication did not qualify as such.
Objectives
Construction of a simple risk score for patients at high
risk of potentially preventable ‘medical’ and ‘severe
medical’ complications leading to LOS >4 days or
readmission. Secondary outcomes were to construct
simple risk scores for ‘surgical’ and ‘total’ potentially pre-
ventable complications.
Statistics
Data distribution was analysed using the Kolmogorov-
Smirnov test. Results for non-parametric data are given
as medians with IQRs. Risk prediction models for ‘total’,
‘medical’, ‘severe’ medical and ‘surgical’ complications
were constructed using univariate analysis followed by
stepwise multiple logistic regression. A signiﬁcance level
≤0.10 was chosen for univariate analysis to reduce the
risk of excluding variables with signiﬁcant associations
after adjustments.29 The included variables were:
gender, age ≥75, ≥80 and ≥85 years (cut-offs based on
previous work,15 with only the most signiﬁcant age
dichotomisations included in the multiple regression),
living alone, smoking, alcohol use of >24 g/day, use of
walking aids, body mass index (BMI) >30, surgical pro-
cedure (THA vs TKA), hypertension, hypercholesterol-
aemia, antihyperglycaemic treatment for diabetes,
pharmacologically treated psychiatric disorder,25 cardiac
disease, pulmonary disease, previous cerebral stroke,
previous venous thromboembolic event, use of anticoa-
gulants (vitamin K antagonists, dabigatranetexilate or
rivaroxaban). Place of surgery was included in the mul-
tiple logistic regression analysis as a random effect. A sig-
niﬁcance level of 0.05 was chosen for multiple
regression models. Two-way interactions between signiﬁ-
cant variables were added and tested. Receiver operating
characteristic of the ﬁnal model was pictured and area
under the curve (AUC) was calculated. To assess
whether accuracy could be improved, we used three dif-
ferent weightings for combining the included variables
into a total score: one using the ORs, one using a base-
line value of 1 for each variable, and one using a value
of 1 in case of an OR <1.90 and 2 if ≥1.90. The ﬁnal
analysis was done on the largest possible data set, but
with minor variations due to missing data for speciﬁc
preoperative characteristics (table 2).
For the risk score, we calculated the positive (PPV)
and negative predictive values (NPV), and the number
needed to treat (NNT) with different weighting and
chose combinations of the included variables to ﬁnd a
clinically relevant cut-off for ‘high-risk’ patients. We also
calculated how many complications would have been
Table 2 Preoperative characteristics
THA 4565 (52.2)
TKA 4172 (47.8)
Age/years median (IQR) 68 (67–75)
<50 524 (6.0)
51–60 1465 (16.8)
61–65 1384 (15.8)
66–70 1717 (19.7)
71–75 1546 (17,7)
76–80 1191 (13.6)
81–85 650 (7.4)
>85 260 (3.0)
Females 5031 (57.8)
BMI median (IQR) 27.7 (24.8–31.2)
<18.5 69 (0.8)
18.5–24.9 2284 (26.2)
25.0–29.9 3475 (39.9)
30–34.9 1960 (22.5)
35–39.9 685 (7.9)
>40 237 (2.7)
Missing 27 (0.3)
BMI ≥30 2882 (33.0)
Missing 27 (0.3)
Anaemia 1107 (12.8)
Missing 77 (0.9)
Walking aids 2126 (24.8)
Missing 177 (2.0)
Living alone 2954 (33.8)
With others 5783 (66.2)
Missing 0 (0.0)
Smoking 1325 (15.3)
Missing 90 (1.0)
Alcohol >24 g/day 599 (6.9)
Missing 73 (0.8)
Hypertension 4585 (52.8)
Missing 55 (0.6)
Hypercholesterolaemia 2572 (29.4)
Missing 80 (0.9)
Diabetes with antihyperglycaemic
treatment
861 (9.9)
Missing 35 (0.4)
Anticoagulant treatment* 445 (5.1)
Missing 0 (0.0)
Cardiac disease 1083 (12.4)
Missing 128 (1.5)
Pulmonary disease 658 (7.6)
Missing 73 (0.8)
PsD with pharmacological treatment 975 (11.2)
Missing 393 (4.5)
Previous stroke 528 (6.1)
Missing 129 (1.5)
Previous venous thromboembolic event 469 (5.5)
Missing 152 (1.7)
Parentheses are per cent unless otherwise specified.
*Vitamin K antagonists or new oral anticoagulants.
BMI, body mass index; PsD, psychiatric disorder; THA, total hip
arthroplasty; TKA, total knee arthroplasty.
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avoided in our study cohort if applying hypothetical
interventions reducing complications by 50%, 33% and
25%. When testing differences in occurrences of speciﬁc
complications, we used a signiﬁcance level of 0.001 to
account for multiple comparisons. Analysis was done
using SPSS V.20 ((IBM Corporation, Armonk, New York,
USA) and SAS V.9.3 (SAS institute inc, Cary, North
Carolina, USA))
RESULTS
A total of 8804 procedures in 8288 patients were eligible
for analysis. We excluded 67 (0.8%) procedures in
patients coming from nursing homes or other institu-
tions, as these composed a very small and potentially dif-
ferent patient population. Of the remaining 8737
procedures, 1362 (15.6%) were followed by complica-
tions leading to either LOS >4 days or readmissions, but
only 568 complications (6.4% of all procedures, range
per year: 5.8–7.0%) were potentially preventable). Of
379 (4.2%) ‘medical’ complications of which 213 (2.3%)
were ‘severe’, 258 (3.0%) resulted in LOS >4 days and
121 (1.4%) resulted in readmissions. Correspondingly,
of 189 (2.2%) ‘surgical’ complications of which 177
(2.0%) were ‘severe’, 13 (0.1%) and 176 (2.0%) resulted
in LOS >4 days and readmissions, respectively (see
online table supplementary data 1 for details).
Primary objectives: ‘medical’ and ‘severe medical’
complications
The ﬁnal regression model for ‘medical’ complications
included the following seven characteristics: age
≥80 years, hypertension, use of anticoagulants, pulmon-
ary disease, pharmacologically treated psychiatric dis-
order, anaemia and use of walking aids (see online
supplementary data 2 table S1 for results of logistic
regression). The AUC was between 0.75 and 0.76 regard-
less of weighting, and with an estimated risk of develop-
ing a ‘medical’ complication leading to either LOS
>4 days or readmission of 67% with seven preoperative
predictors. No patient had seven predictors and only 6
(0.07%) patients had six. All combinations of predictors
had a NPV of ≥0.96, but the highest PPV was only 0.32
(≥5 predictors); these patients were only 0.9% of the
population (table 3). Assigning a value of 1 for each pre-
dictor and using a cut-off of ≥3 selected 14.2% of
patients with a 12.9% complication rate and encompass-
ing 45.0% of all ‘medical’ complications. If excluding
hypertension, which was present in 52.4% of the popula-
tion, from the relevant medical predictors (medical pre-
dictors excluding hypertension, MPEH) and using a
cut-off of ≥2, 19.1% (range13.9–21.2% per department)
of patients would be risk patients (table 3 ﬁgure 1)
encompassing 55.7% (range 50.0–65.7% per depart-
ment) of ‘medical’ complications. The NNT with a hypo-
thetical intervention reducing ‘medical’ complications
by 25% in patients with ≥2 MPEH was 34, and 46
(14.0%) complications would have been avoided in the
cohort. No improvement in predictive ability was found
when assigning a value of 2 to predictors with an OR of
≥1.9 (maximum of 12), regardless of excluding hyper-
tension (table 3).
When analysing the cases of ‘severe medical’ compli-
cations, we found that anaemia and hypertension no
longer qualiﬁed as predictors (see online supplementary
data 2 table S2 for results of logistic regression). AUC
was 0.75 and the estimated risk was 45.1% with all ﬁve
predictors. No patient had all predictors and only 0.3%
had 4. Using a cut-off of ≥2 of these ﬁve predictors
would result in 14.9% risk patients, who contributed
48.4% of all severe complications. However, if using ≥2
MPEH as cut-off, 54.2% of the severe complications
occurred in risk patients (table 3 and ﬁgure 1), resulting
in a NNT of 59 and avoiding 26 (14.0%) complications.
Overall, the most frequent complications in patients
with ≥2 MPEH were: anaemia, mobilisation issues, pul-
monary, cardiac, renal/ﬂuid related and falls. In con-
trast, there were few cases of opioid-related morbidity,
delirium, thromboembolic events and severe renal com-
plications (ﬁgure 2A,B). Of ‘severe’ complications, the
signiﬁcantly more were pulmonary, cardiac and due to
falls in patients with ≥2 MPEH versus patients with <2
MPEH (p<0.0001; ﬁgure 3). The majority of pulmonary
and cardiac complications were pneumonias (n: 23) and
arrhythmias (n:18) occurring in 1.5% and 1.2% of
patients, respectively, with ≥2 MPEH.
Secondary objectives: ‘surgical’ and ‘total’ complications
For ‘surgical’ complications, the ﬁnal regression model
included three characteristics: joint of surgery, use of
walking aids and cardiac disease. As only three
characteristics, one of which was the surgical procedure,
were associated with ‘surgical’ morbidity no clinically
relevant prediction based on preoperative risk factors
was possible. However, there were more hip dislocations
in patients with THA (3.6% vs 1.5%, p<0.001) and no
MUAs in patients with TKA (0.0% vs 0.9%, p=0.006)
with ≥2 MPEH. For details on analysis on ‘surgical’ com-
plications see supplementary data 3. Multiple logistic
regression analysis on ‘total’ complications found a sig-
niﬁcant association with the following preoperative
characteristics: age ≥75 years, hypertension, cardiac
disease, pulmonary disease, pharmacologically treated
psychiatric disorder, anaemia and use of walking aids.
The risk of developing a complication leading to either
LOS >4 days or readmission was 49.8% if all seven pre-
dictors were present prior to surgery; however, no
patient had all seven predictors and only 36 (0.5%)
patients had six. For details of analysis on ‘total’ compli-
cations see supplementary data 4.
Mortality
Sixteen (0.2%) deaths occurred within 30 days after
surgery. Of these, one was unrelated to surgery (cancer
related) and one was in a patient with some missing pre-
operative data (pulmonary embolism). Of the 14
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Table 3 Predictive ability of combinations of significant predictors
Outcome Characteristic (%)
Events (%) Percentage
of events
Percentage
correct Sensitivity Specificity PPV NPV
NNT
50
NNT
33
NNT
25
AE
50
AE
33
AE
25Yes No
‘Medical’
complications
n: 327
Age ≥80 years (12.3) 118 (11.9) 872 36.1 86.5 36.09 88.67 0.12 0.97 17 25 34 59 39 30
Walking aids (24.2) 187 (9.6) 1753 57.2 76.4 57.19 77.22 0.10 0.98 21 31 41 94 62 47
Hypertension (52.4) 221 (5.3) 3982 67.6 49.0 67.58 48.25 0.05 0.97 38 57 76 111 74 55
Anticoagulants (5.0) 42 (10.5) 357 12.8 92.0 12.84 95.36 0.11 0.96 19 29 38 21 14 11
Anaemia (12.4) 94 (9.4) 904 28.7 85.8 28.75 88.25 0.09 0.97 21 32 42 47 31 24
Psychological disorder (11.6) 78 (8.4) 851 23.9 86.3 23.85 88.94 0.08 0.96 24 36 48 39 26 20
Pulmonary disease (7.4) 46 (7.7) 551 14.1 89.6 14.07 92.84 0.08 0.96 26 39 52 23 15 12
≥3 predictors (14.3) 147 (12.9) 996 45.0 85.3 44.95 87.05 0.13 0.97 16 23 31 74 49 37
≥4 predictors (4.3) 68 (19.8) 275 20.8 93.3 20.80 96.43 0.20 0.97 10 15 20 34 23 17
≥5 predictors (0.9) 24 (32.4) 50 7.3 95.6 7.34 99.35 0.32 0.96 6 9 12 12 8 6
≥4 MP2 (18.1) 174 (12.0) 1276 53.2 82.2 53.21 83.42 0.12 0.98 17 25 33 87 58 44
≥5 MP2 (12.8) 139 (13.6) 886 42.5 86.6 42.51 88.48 0.14 0.97 15 22 29 70 46 35
≥2 MPEH (19.1) 182 (11.9) 1348 55.7 81.4 55.66 82.50 0.12 0.98 17 25 34 91 61 46
≥3 MPEH2 (5.6) 83 (18.5) 366 55.7 92.4 25.38 95.14 0.18 0.97 11 16 22 42 28 21
‘Severe medical’
complications
n:213
Age ≥80 years (12.3) 70 (7.0) 928 36.8 87.1 36.84 88.32 0.07 0.98 29 43 57 35 23 18
Walking aids (24.2) 108 (5.5) 1861 56.8 76.1 56.84 76.57 0.05 0.99 36 55 73 54 36 27
Anticoagulants (4.9) 27 (6.7) 378 14.2 93.3 14.21 95.24 0.07 0.98 30 45 60 14 9 7
Psychological disorder (11.6) 48 (5.1) 895 25.3 87.2 25.26 88.73 0.05 0.98 39 59 79 24 16 12
Pulmonary disease (7.5) 31 (5.11) 577 16.3 90.9 16.32 92.73 0.05 0.98 39 59 78 16 10 8
≥2 predictors (14.9) 92 (7.6) 1122 48.4 85.0 48.42 85.87 0.08 0.99 26 40 53 46 31 23
≥3 predictors (3.1) 31 (12.4) 218 16.3 95.4 16.32 97.26 0.12 0.98 16 24 32 16 10 8
≥4 predictors (0.3) 6 (23.1) 20 3.2 97.5 3.16 99.75 0.23 0.98 9 13 17 3 2 2
≥3 MP (14.3) 83 (7.3) 1060 43.7 85.5 44.62 86.47 0.07 0.99 28 41 55 42 28 21
≥4 MP2 (18.1) 98 (7.0) 1352 51.6 82.1 52.69 82.74 0.07 0.99 30 44 59 49 33 25
≥2 MPEH (19.1) 103 (6.7) 1427 54.2 81.2 55.38 81.79 0.07 0.99 30 45 59 52 34 26
Number of included patients is 8021 for ‘medical’ complications and 8132 for ‘severe medical’ complications due to 8.1% and 6.9% with missing data on relevant predictors.
AE 25, avoided events in the cohort with 25% event reduction; AE 30, avoided events in the cohort with 30% event reduction; AE 50, avoided events in the cohort with 50% event reduction;
MP2, ‘medical’ predictors with two points if OR ≥1.9; MPEH, medical predictors excluding hypertension; MPEH2, ‘medical’ predictors excluding hypertension and two points if OR ≥1.9; NNT 25,
number needed to treat if there is a 25% event reduction; NNT 30, number needed to treat if there is a 30% event reduction; NNT 50, number needed to treat if there is a 50% event reduction;
NPN, negative predictive value; PPV, positive predictive value.
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potentially (0.1%) surgery-related deaths, 11 (0.7%)
were in patients with ≥2 MPEH versus 3 (0.04%) with <2
MPEH (p<0.001).
DISCUSSION
Predicting which patients will develop complications
after surgery is difﬁcult, but focus on improving post-
operative outcomes through better perioperative care is
increasing.13 30 31 Our study in fast-track THA and TKA
found that although identiﬁcation of high-risk patients
for potentially preventable ‘medical’ complications
based on preoperative risk factors is statistically possible,
the clinical relevance is limited by diverse types of com-
plications and a high NNT. Furthermore, we found that
predictors for ‘surgical’ and ‘medical’ complications
were not the same, thus demonstrating the importance
of distinguishing between these, especially considering
that neither statistically nor clinically relevant preopera-
tive prediction was possible regarding ‘surgical’ compli-
cations. Finally, our study demonstrated the necessity of
considering preventability of complications, as this was
the case in only about 40% of patients with LOS >4 days
or readmissions. Similar results have been reported in
mixed patients, where the fraction of preventable
unplanned readmissions is about 20–30%.32 33
Apart from the obstacles of few potentially ‘prevent-
able’ complications and different predictors of poten-
tially preventable ‘medical’ and ‘surgical’ complications,
there is the problem of deﬁning suitable strategies for
Figure 1 Relationship between
per cent of complications and
percentage of population for
combinations of predictors and
weightings. MPEH, medical
predictors excluding
hypertension.
Figure 2 Occurrence and fraction of specific types of ‘medical’ complications in patients with <2 ‘medical’ predictors excluding
hypertension (MPEH) n: 6491 vs ≥2 MPEH n: 1530. TCI, transient cerebral ischaemia; VTE, venous thromboembolic event.
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reducing these. Thus, ‘medical’ complications may be
reduced by further optimisation of the fast-track meth-
odology, while ‘surgical’ complications would be
dependent on surgical expertise.11
In our opinion, the most clinically relevant cut-off for
deﬁning patients at high risk of potentially preventable
‘medical’ complications was ≥2 MPEH. This encom-
passed about 20% of all patients, with minor variation
between departments, and these accounted for more
than half of the ‘medical’ complications. Interventional
studies targeting patients with ≥2 MPEH could focus on
falls, mobilisation issues, pneumonia and cardiac
arrhythmia as these occurred most frequently.
Unfortunately, a signiﬁcant reduction of such diverse
postoperative ‘medical’ complications is likely to require
a multimodal interventional strategy, including correc-
tion of preoperative anaemia and ward rounds by anaes-
thesiologists or geriatricians. Such attempts have shown
promising results both in orthopaedic and in other
types of surgery.34–36 However, designing the required
randomised trials within a standardised fast-track proto-
col will be challenging, especially considering the large
number of patients needed.
Prediction of ‘surgical’ complications was all but
impossible in the present study, but it is interesting that
no cases of MUA were present in the patients with ≥2
MPEH, supporting our previous ﬁndings of MUA being
associated with younger age and independence from
walking aids.37 Finally, how to reduce the number of hip
dislocations in patients with ≥2 MPEH deserves further
study.
Previous studies of smaller cohorts contributing to the
present study15 17 18 20 and in other study
cohorts14 16 19 38 have found a reduced importance of
conventional risk factors and decreased postoperative
morbidity in fast-track THA and TKA compared with
studies with conventional perioperative care. This was
conﬁrmed in the present study where smoking, alcohol
use, diabetes requiring antihyperglycaemic treatment
and a BMI of >30 were not associated with postoperative
complications, and even when using ≥2 MPEH to deﬁne
patients at risk of ‘medical’ complications, the high NNT
limited the clinical relevance. However, whether this also
applies to other types of fast-track surgery and to other
patient populations remains unknown. Thus, character-
isation of the high-risk patients and postoperative mor-
bidity in other fast-track surgical procedures and
populations is needed. This may be especially important
regarding obesity, where it could be argued that our BMI
cut-off should have been placed at 35 or beyond.39
Our study is subject to some limitations. As it was
observational, we can only provide associations.
However, the intention was to deﬁne a clinically relevant
group of high-risk patients, and not to demonstrate caus-
ality between preoperative characteristics and speciﬁc
complications. Furthermore, evaluation of complications
is subjective and the inclusion of three or more
reviewers to solve potential disagreements by majority
vote may have been preferable. It could also be argued
that we should have used an existing index for evalu-
ation of postoperative complications. Unfortunately,
existing indices are subject to limitations, for example,
the Dindo-Clavien index focuses on the most severe
complications, with no distinction between ‘medical’ or
‘surgical’ morbidity and without consideration of pre-
operative risk factors.40 The Comprehensive
Complication Index expresses all complications as a
single score,41 but does not consider the order of occur-
rence or whether the initial complications led to subse-
quent complications. The Postoperative Morbidity
Survey42 may be inadequate for recording morbidity in
fast-track orthopaedic patients. A weakness from evaluat-
ing patient records is that unrecorded information may
have led to misclassiﬁcation regarding the preventability
Figure 3 Occurrence and fraction of specific types of ‘severe medical’ complications in patients with <2 ‘medical’ predictors excluding
hypertension (MPEH) n: 6491 vs ≥2 MPEH n: 1530. TCI, transient cerebral ischaemia; VTE, venous thromboembolic event.
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of the complication and whether it was ‘medical’ or ‘sur-
gical’. Nonetheless, this approach is likely to be superior
to using diagnostic codes, and has been proposed as the
best way of determining preventability of readmissions.43
Finally, the results should ideally be conﬁrmed in a dif-
ferent cohort having fast-track THA and TKA to conﬁrm
the validity and predictive ability of the identiﬁed risk
factors.
The strengths of our study include a detailed analysis
of postoperative morbidity distinguishing between what
came ﬁrst; whether ‘medical’ or ‘surgical’, it made use
of prospectively recorded data on patient characteristics,
and had a well-described standardised fast-track setup26
with consecutive unselected patients and nationwide
databases with complete follow-up.27 28
In conclusion, this study demonstrates the importance
of distinguishing between ‘medical’ and ‘surgical’ mor-
bidity when investigating the role of preoperative risk
factors. Additionally, the predictive value of the six rele-
vant predictors for developing potentially preventable
‘medical’ complications was limited and no clinically rele-
vant prediction of ‘surgical’ complications was possible.
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